October 19, 2007
Harvard Licensing Deal Reflects Its 'Public Mission'
Harvard University, one of the originators of a statement of how institutions can serve the public good while commercializing technology, has taken the message to heart.
A deal that the university has just signed for licensing a new vaccine technology, a top official says, reflects many of the principles espoused in the statement.
The invention involves a biochemical method of producing vaccines that could prove to be less complex than many existing approaches.
The
This is an article for subscribers only. You may access this article by purchasing a:
Digital or Print Subscription
Web Pass
Already have an account? Log In Now.
-
Off Beat

-
The Chronicle Review

-
Administration


